DK160288C - Fremgangsmaade til fremstilling af liposomer, til hvilke der er bundet biologisk aktive substanser - Google Patents
Fremgangsmaade til fremstilling af liposomer, til hvilke der er bundet biologisk aktive substanserInfo
- Publication number
- DK160288C DK160288C DK552280A DK552280A DK160288C DK 160288 C DK160288 C DK 160288C DK 552280 A DK552280 A DK 552280A DK 552280 A DK552280 A DK 552280A DK 160288 C DK160288 C DK 160288C
- Authority
- DK
- Denmark
- Prior art keywords
- liposomes
- procedure
- preparation
- biologically active
- active substances
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G01N33/586—Liposomes, microcapsules or cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Public Health (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Dispersion Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU79HU299A HU184141B (en) | 1979-12-27 | 1979-12-27 | Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof |
HUHU000299 | 1979-12-27 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK552280A DK552280A (da) | 1981-06-28 |
DK160288B DK160288B (da) | 1991-02-25 |
DK160288C true DK160288C (da) | 1991-08-05 |
Family
ID=10997378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK552280A DK160288C (da) | 1979-12-27 | 1980-12-23 | Fremgangsmaade til fremstilling af liposomer, til hvilke der er bundet biologisk aktive substanser |
Country Status (21)
Country | Link |
---|---|
US (1) | US4396630A (es) |
JP (1) | JPS57112334A (es) |
BE (1) | BE886884A (es) |
CA (1) | CA1165237A (es) |
CH (1) | CH655246A5 (es) |
CS (1) | CS241478B2 (es) |
DD (1) | DD158738A5 (es) |
DE (1) | DE3048815A1 (es) |
DK (1) | DK160288C (es) |
ES (1) | ES498048A0 (es) |
FR (1) | FR2472386B1 (es) |
GB (1) | GB2066203B (es) |
HU (1) | HU184141B (es) |
IT (1) | IT1150073B (es) |
NL (1) | NL8007041A (es) |
PL (1) | PL228755A1 (es) |
PT (1) | PT72261B (es) |
RO (1) | RO81371A (es) |
SE (1) | SE453537B (es) |
SU (1) | SU1487802A3 (es) |
YU (1) | YU44413B (es) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4598051A (en) * | 1980-03-12 | 1986-07-01 | The Regents Of The University Of California | Liposome conjugates and diagnostic methods therewith |
US4806466A (en) * | 1981-10-29 | 1989-02-21 | The Regents Of The University Of California | Cell agglutination reagent comprising conjugates of antibody covalently bound to liposomes |
FR2521565B1 (fr) * | 1982-02-17 | 1985-07-05 | Dior Sa Parfums Christian | Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees |
DD247570A3 (de) * | 1983-01-14 | 1987-07-15 | Univ Berlin Humboldt | Vesikulaeres trenn-, fuell- und traegermaterial |
US4515736A (en) * | 1983-05-12 | 1985-05-07 | The Regents Of The University Of California | Method for encapsulating materials into liposomes |
US5059591B1 (en) * | 1983-05-26 | 2000-04-25 | Liposome Co Inc | Drug preparations of reduced toxicity |
US4708861A (en) * | 1984-02-15 | 1987-11-24 | The Liposome Company, Inc. | Liposome-gel compositions |
US5916588A (en) * | 1984-04-12 | 1999-06-29 | The Liposome Company, Inc. | Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use |
US6090406A (en) * | 1984-04-12 | 2000-07-18 | The Liposome Company, Inc. | Potentiation of immune responses with liposomal adjuvants |
GB2160312B (en) * | 1984-04-13 | 1987-09-16 | South African Inventions | Adjuvant for immunisation |
PT78628B (en) * | 1984-05-02 | 1986-06-18 | Liposome Co Inc | Pharmaceutical composition with reduced toxicity |
US4619904A (en) * | 1984-10-29 | 1986-10-28 | General Electric Company | Agglutinating immunoassay using protein-coated liquid droplets |
US4857319A (en) * | 1985-01-11 | 1989-08-15 | The Regents Of The University Of California | Method for preserving liposomes |
US5266329A (en) * | 1985-10-31 | 1993-11-30 | Kv Pharmaceutical Company | Vaginal delivery system |
JP2519029B2 (ja) * | 1985-10-31 | 1996-07-31 | ケ−・ブイ・ファ−マシュ−ティカル・カンパニ− | 腟内送達用製剤 |
US4790987A (en) * | 1985-11-15 | 1988-12-13 | Research Corporation | Viral glycoprotein subunit vaccine |
CA1338736C (fr) * | 1986-12-05 | 1996-11-26 | Roger Baurain | Microcristaux comportant une substance active presentant une affinite pour les phospholipides, et au moins un phospholipide, procede de preparation |
US5688519A (en) * | 1987-04-06 | 1997-11-18 | Leonard; Robert J. | Flash-flow fused medicinal implants |
US4748024A (en) * | 1987-04-06 | 1988-05-31 | Endocon, Inc. | Flash flow fused medicinal implants |
WO1990001948A1 (en) * | 1988-08-25 | 1990-03-08 | The Liposome Company, Inc. | Influenza vaccine and novel adjuvants |
EP0374296B1 (en) * | 1988-12-22 | 1995-02-01 | Dade International Inc. | Lipohaptens and use of carrier-bound lipohaptens in immunoassays |
US5100662A (en) * | 1989-08-23 | 1992-03-31 | The Liposome Company, Inc. | Steroidal liposomes exhibiting enhanced stability |
JPH07113641B2 (ja) * | 1989-11-17 | 1995-12-06 | 積水化学工業株式会社 | 梅毒診断試薬の製造方法 |
NL9000207A (es) * | 1990-01-29 | 1991-08-16 | Duphar Int Res | |
CA2086094C (en) * | 1990-06-29 | 2000-05-30 | Gail L. Barchfeld | Vaccine compositions containing liposomes |
US5709879A (en) * | 1990-06-29 | 1998-01-20 | Chiron Corporation | Vaccine compositions containing liposomes |
IE912535A1 (en) * | 1990-07-27 | 1992-01-29 | Res Dev Foundation | Liposomes that Provide Thymic Dependent Help to Weak Vaccine¹Antigens |
WO1992004887A1 (en) * | 1990-09-25 | 1992-04-02 | Kyowa Hakko Kogyo Co., Ltd. | Induction of cytotoxic t cell |
US6048531A (en) * | 1991-04-15 | 2000-04-11 | Albany Medical College | Immunogenic composites capable of stimulating production of anti-peptide antibodies, pharmaceutical compositions employing these composites and methods of selectively inducing production of anti-peptide antibodies |
US5336507A (en) * | 1992-12-11 | 1994-08-09 | Sterling Winthrop Inc. | Use of charged phospholipids to reduce nanoparticle aggregation |
GB9320668D0 (en) | 1993-10-07 | 1993-11-24 | Secr Defence | Liposomes containing particulare materials |
AUPM500494A0 (en) * | 1994-04-12 | 1994-05-05 | Minister For Agriculture & Rural Affairs For The State Of New South Wales, The | Composition for use in increasing mucosal immunity |
JP4524071B2 (ja) * | 2000-11-09 | 2010-08-11 | ネオファーム、インコーポレイティッド | Sn−38脂質複合体及び使用方法 |
WO2003030864A1 (en) * | 2001-05-29 | 2003-04-17 | Neopharm, Inc. | Liposomal formulation of irinotecan |
EP1487413A4 (en) * | 2002-03-05 | 2010-11-10 | Transave Inc | INHALATION SYSTEM FOR THE TREATMENT OF INTRACELLULAR INFECTIONS |
US20060030578A1 (en) * | 2002-08-20 | 2006-02-09 | Neopharm, Inc. | Pharmaceutically active lipid based formulation of irinotecan |
AU2003296897A1 (en) * | 2002-08-20 | 2004-05-04 | Neopharm, Inc. | Pharmaceutical formulations of camptothecine derivatives |
US7718189B2 (en) | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
US7879351B2 (en) * | 2002-10-29 | 2011-02-01 | Transave, Inc. | High delivery rates for lipid based drug formulations, and methods of treatment thereof |
AU2003304204B2 (en) * | 2002-10-29 | 2009-12-24 | Insmed Incorporated | Sustained release of antiinfectives |
KR100651728B1 (ko) * | 2004-11-10 | 2006-12-06 | 한국전자통신연구원 | 정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법 |
WO2006090816A1 (ja) * | 2005-02-25 | 2006-08-31 | Mie University | リポソームワクチンの作製法 |
AU2006322076C1 (en) | 2005-12-08 | 2013-11-14 | Insmed Incorporated | Lipid-based compositions of antiinfectives for treating pulmonary infections |
WO2008137717A1 (en) | 2007-05-04 | 2008-11-13 | Transave, Inc. | Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof |
US9119783B2 (en) | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
US9114081B2 (en) | 2007-05-07 | 2015-08-25 | Insmed Incorporated | Methods of treating pulmonary disorders with liposomal amikacin formulations |
US9333214B2 (en) | 2007-05-07 | 2016-05-10 | Insmed Incorporated | Method for treating pulmonary disorders with liposomal amikacin formulations |
AU2013266400B2 (en) | 2012-05-21 | 2017-06-22 | Insmed Incorporated | Systems for treating pulmonary infections |
RU2018135921A (ru) | 2012-11-29 | 2019-02-05 | Инсмед Инкорпорейтед | Стабилизированные составы ванкомицина |
LT3466432T (lt) | 2014-05-15 | 2020-12-28 | Insmed Incorporated | Būdai, skirti plaučių netuberkuliozinėms mikobakterinėms infekcijoms gydyti |
EP3773505A4 (en) | 2018-03-30 | 2021-12-22 | Insmed Incorporated | PROCESS FOR THE CONTINUOUS MANUFACTURING OF LIPOSOMAL MEDICINAL PRODUCTS |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3265629A (en) * | 1958-12-22 | 1966-08-09 | Ncr Co | Coating by phase separation |
DE2249552A1 (de) * | 1971-10-12 | 1973-05-30 | Inchema S A | Verfahren zur inkapsulation von insbesondere wasserloeslichen verbindungen |
GB1502774A (en) * | 1974-06-25 | 1978-03-01 | Nat Res Dev | Immunological preparations |
JPS5126213A (ja) * | 1974-08-21 | 1976-03-04 | Tanabe Seiyaku Co | Johoseibiryushiseizaino seiho |
GB1564500A (en) * | 1975-09-29 | 1980-04-10 | Wellcome Found | Biological preparations |
GB1523965A (en) * | 1976-03-19 | 1978-09-06 | Ici Ltd | Pharmaceutical compositions containing steroids |
GB1575343A (en) * | 1977-05-10 | 1980-09-17 | Ici Ltd | Method for preparing liposome compositions containing biologically active compounds |
IT1110989B (it) * | 1979-01-19 | 1986-01-13 | Erba Farmitalia | Forme farmaceutiche costitutite da liposomi e procedimenti relativi |
FR2416008A1 (fr) * | 1978-02-02 | 1979-08-31 | Oreal | Lyophilisats de liposomes |
US4235871A (en) * | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
JPS55118415A (en) * | 1979-02-28 | 1980-09-11 | Pii Papahadojiyopo Dometoriosu | Method of encapsulating biologically active substance in lipoid cell |
-
1979
- 1979-12-27 HU HU79HU299A patent/HU184141B/hu unknown
-
1980
- 1980-12-12 CH CH9166/80A patent/CH655246A5/de not_active IP Right Cessation
- 1980-12-19 US US06/218,126 patent/US4396630A/en not_active Expired - Fee Related
- 1980-12-22 ES ES498048A patent/ES498048A0/es active Granted
- 1980-12-22 SE SE8009068A patent/SE453537B/sv not_active IP Right Cessation
- 1980-12-22 PT PT72261A patent/PT72261B/pt unknown
- 1980-12-23 DE DE19803048815 patent/DE3048815A1/de active Granted
- 1980-12-23 GB GB804281A patent/GB2066203B/en not_active Expired
- 1980-12-23 CS CS809246A patent/CS241478B2/cs unknown
- 1980-12-23 DK DK552280A patent/DK160288C/da active
- 1980-12-23 PL PL22875580A patent/PL228755A1/xx unknown
- 1980-12-24 CA CA000367565A patent/CA1165237A/en not_active Expired
- 1980-12-24 IT IT26950/80A patent/IT1150073B/it active
- 1980-12-24 NL NL8007041A patent/NL8007041A/nl not_active Application Discontinuation
- 1980-12-24 FR FR8027496A patent/FR2472386B1/fr not_active Expired
- 1980-12-25 RO RO80102952A patent/RO81371A/ro unknown
- 1980-12-26 YU YU3290/80A patent/YU44413B/xx unknown
- 1980-12-26 SU SU803220898A patent/SU1487802A3/ru active
- 1980-12-26 JP JP55184157A patent/JPS57112334A/ja active Granted
- 1980-12-29 BE BE0/203337A patent/BE886884A/fr not_active IP Right Cessation
-
1981
- 1981-01-30 DD DD81227326A patent/DD158738A5/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE3048815A1 (de) | 1981-09-10 |
GB2066203B (en) | 1984-01-11 |
BE886884A (fr) | 1981-06-29 |
CA1165237A (en) | 1984-04-10 |
PT72261A (en) | 1981-01-01 |
SE8009068L (sv) | 1981-06-28 |
IT8026950A0 (it) | 1980-12-24 |
IT1150073B (it) | 1986-12-10 |
CS241478B2 (en) | 1986-03-13 |
CH655246A5 (de) | 1986-04-15 |
DD158738A5 (de) | 1983-02-02 |
GB2066203A (en) | 1981-07-08 |
YU44413B (en) | 1990-08-31 |
YU329080A (en) | 1984-04-30 |
RO81371A (ro) | 1984-04-02 |
FR2472386A1 (es) | 1981-07-03 |
PL228755A1 (es) | 1982-02-15 |
ES8201316A1 (es) | 1981-12-16 |
CS924680A2 (en) | 1985-07-16 |
DK160288B (da) | 1991-02-25 |
FR2472386B1 (es) | 1985-08-23 |
JPS57112334A (en) | 1982-07-13 |
RO81371B (ro) | 1983-11-02 |
ES498048A0 (es) | 1981-12-16 |
PT72261B (en) | 1981-11-05 |
HU184141B (en) | 1984-07-30 |
NL8007041A (nl) | 1981-07-16 |
SU1487802A3 (ru) | 1989-06-15 |
DK552280A (da) | 1981-06-28 |
SE453537B (sv) | 1988-02-08 |
JPH0314814B2 (es) | 1991-02-27 |
US4396630A (en) | 1983-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK160288C (da) | Fremgangsmaade til fremstilling af liposomer, til hvilke der er bundet biologisk aktive substanser | |
DK148752C (da) | Fremgangsmaade til fremstilling af cyclosporinderivater | |
DK29681A (da) | Fremgangsmaade til fremstilling af immunogammaglobulin | |
DK132980A (da) | Fremgangsmaade til fremstilling af substituerede piperidinderivater | |
DK133080A (da) | Fremgangsmaade til fremstilling af substituerede piperidinderivater | |
DK156779A (da) | Fremgangsmaade til fremstilling af cycloalkyltriazoler | |
DK129879A (da) | Fremgangsmaade til fremstilling af n-heterocyclyl-4-piperidinaminer | |
DK6180A (da) | Fremgangsmaade til fremstilling af 2-pennemforbindelser | |
DK311580A (da) | Fremgangsmaade til fremstilling af oxoalkylxanthiner | |
DK274580A (da) | Fremgangsmaade til fremstilling af tripeptidamider | |
DK149623C (da) | Fremgangsmaade til fremstilling af alfa-hydroxycarboxylsyreamider | |
DK4280A (da) | Fremgangsmaade til fremstilling af pleuromutilinderivater | |
DK153791C (da) | Fremgangsmaade til fremstilling af 7-hydroxycumaraner | |
DK481280A (da) | Fremgangsmaade til fremstilling af piperidylbenzimidazolinonderivater | |
DK262180A (da) | Fremgangsmaade til fremstilling af alkyl-2-chlorpropionater | |
DK274680A (da) | Fremgangsmaade til fremstilling af tripeptidamider | |
DK414180A (da) | Fremgangsmaade til fremstilling af dibenzazepinderivater | |
DK150471C (da) | Fremgangsmaade til fremstilling af trifluormethylphenoler | |
DK69680A (da) | Fremgangsmaade til fremstilling af diorganomagnesiumforbindelser | |
DK66079A (da) | Fremgangsmaade til fremstilling af detoxificerede praeparater af cytostatika | |
DK16779A (da) | Fremgangsmaade til fremstilling af betaendoprphinanaloge | |
DK145179A (da) | Fremgangsmaade til fremstilling af 4-methyl-5-hydroxymethyl-imidazol | |
DK318280A (da) | Fremgangsmaade til fremstilling af naphthyridinderivater | |
DK529278A (da) | Fremgangsmaade til fremstilling af farmaceutisk virksomme thiolestere | |
DK185179A (da) | Fremgangsmaade til fremstilling af 3-halogen-2-hydroxyalkyltrialkylammoniumunchlorider |